Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03912571 · ClinicalTrials.gov registry record
Sleep Disordered Breathing and Alzheimer's Disease Biomarkers in Normal Aging and Mild Cognitive Impairment
A clinical trial of Sleep Disorder, sponsored by NYU Langone Health.
- Completed
- Registry status
- 28
- Enrollment target
- 1
- Study location
NCT03912571 is a study of Sleep Disorder that has completed, run by NYU Langone Health. The registered enrollment target is 28 participants, below the 161-participant average among 22 other Sleep Disorder trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03912571, a study of Sleep Disorder, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the sleep patterns of subjects with or without sleep disturbances (insomnia, sleep apnea) and compare these findings with their previous FDG/PIB PET, structural MRI and brain blood flow scams performed during their participation in the Following studies 'Alzheimer's Disease Core Center (ADCC) Clinical Evaluation' (IRB: 2942), MRI Progression Markers of Cognitive Decline in the Elderly' (IRB:09-0586), or 'Imaging Neuro inflammation in Alzheimer's Disease with \[11C\] Arachidonic Acid (AA) and PET'(IRB: 10-00442).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Structural 3T MRI
- DIAGNOSTIC_TEST MRI Based Perfusion Imaging
- DIAGNOSTIC_TEST VR-CO2 MRI Scans
Study Locations (1)
New York
- NYU Langone Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2011-11-13 |
| Est. Completion | 2019-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03912571
The ClinicalTrials.gov registry entry for NCT03912571 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 161-participant average among 22 other Sleep Disorder trials with a reported enrollment target (83% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sleep Disorder appearing as the primary indexed condition, and to 3 interventions - of which Structural 3T MRI is the first listed.
NCT03912571 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03912571 about?
NCT03912571 is a clinical study titled "Sleep Disordered Breathing and Alzheimer's Disease Biomarkers in Normal Aging and Mild Cognitive Impairment". The purpose of this study is to determine the sleep patterns of subjects with or without sleep disturbances (insomnia, sleep apnea) and compare these findings with their previous FDG/PIB PET, structural MRI and brain blood flow scams performed during their participation in the Following studies 'Alz...
What is the current status of trial NCT03912571?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2011-11-13. Estimated completion is 2019-09.
What conditions does trial NCT03912571 study?
This clinical trial studies the following conditions: Sleep Disorder.
What interventions are being tested in trial NCT03912571?
The interventions under investigation include: Structural 3T MRI (DIAGNOSTIC_TEST), MRI Based Perfusion Imaging (DIAGNOSTIC_TEST), VR-CO2 MRI Scans (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03912571?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03912571 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
RECRUITING · Phase 3
-
Study of Disrupted Sleep in Somali Americans
RECRUITING
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment
RECRUITING · NA
-
Baker Gordon Syndrome Natural History Study
RECRUITING
-
Home Apnea Testing in CHildren Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.